Hackernews posts about Pharma CIO
- Amid restructuring, Novo Nordisk directs employees to return to office (www.fiercepharma.com)
- Stealth scores FDA approval for first Barth syndrome treatment (www.fiercepharma.com)
- The Promise and Hurdles of the New Weight-Loss Pills (www.wsj.com)
- Pharma is a small component of US health care spending (www.economist.com)
- AI pro se lawsuit targets $15B shell-company fraud at pharma giant (www.15billiondollarcase.com)
- How Big Pharma Saved My Skin (www.richardhanania.com)
- Pharma Is Pushing $200k Cancer Drugs When Cheaper Doses May Work (www.bloomberg.com)
- A CIO canceled a Microsoft AI deal (www.businessinsider.com)
- Isomorphic Labs deals with pharma companies (endpts.com)
- How Big Pharma Company Stalled Potentially Lifesaving Vaccine Pursuit Profits (www.propublica.org)
- Econ 101 Is Underrated: Pharma Price Controls (marginalrevolution.com)
- Russia is getting Nvidia AI chips from an Indian pharma company (timesofindia.indiatimes.com)
- Genetic Engineering of Plants Can Solve Pharma's Cost Crisis (www.greyb.com)
- Minutes to break your stupid AI Chatbot Customer Service, $XXB pharma company (www.instagram.com)
- Show HN: An open-source implementation of AlphaFold3 (github.com)
- Supreme Court blocks controversial Purdue Pharma opioid settlement (www.washingtonpost.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose (www.fiercepharma.com)
- Pharma Giants, Crypto Profits: How Ozempic Could Redefine Corporate Investment (ion-oaie.medium.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- Moderna's mRNA vaccine manufacturing operations reveal state of the company (www.fiercepharma.com)
- GSK Stalled a Potential Tuberculosis Vaccine in Pursuit of Bigger Profits (www.propublica.org)
- J&J subsidiary floats $6.48B settlement to resolve claims products caused cancer (www.fiercepharma.com)
- GSK stalled its own tuberculosis vaccine (www.propublica.org)
- The Drug Industry Is Having Its Own DeepSeek Moment (www.wsj.com)
- Ozempic Slows Kidney Disease, Novo Nordisk Study Finds (www.wsj.com)